US Stock MarketDetailed Quotes

NRSN NeuroSense Therapeutics

Watchlist
  • 1.270
  • +0.020+1.59%
Close Nov 1 16:00 ET
  • 1.240
  • -0.030-2.35%
Post 20:02 ET
25.16MMarket Cap-1953P/E (TTM)

NeuroSense Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
-82.96%1.21M
-83.34%735K
-62.76%2.64M
-62.76%2.64M
-43.64%4.76M
-31.67%7.09M
-67.89%4.41M
-35.91%7.09M
-35.91%7.09M
--8.44M
-Cash and cash equivalents
-82.96%1.21M
-45.92%735K
-25.49%2.64M
-25.49%2.64M
7.89%4.76M
63.00%7.09M
-84.44%1.36M
-67.97%3.54M
-67.97%3.54M
--4.41M
-Short-term investments
----
----
--0
--0
--0
--0
-38.99%3.05M
--3.55M
--3.55M
--4.03M
Receivables
-13.36%376K
-25.75%421K
26.72%166K
26.72%166K
-27.29%309K
-38.61%434K
152.00%567K
-26.40%131K
-26.40%131K
--425K
-Other receivables
-13.36%376K
-25.75%421K
26.72%166K
26.72%166K
-27.29%309K
-38.61%434K
152.00%567K
-26.40%131K
-26.40%131K
--425K
Prepaid assets
----
----
-43.55%70K
-43.55%70K
----
----
----
-6.06%124K
-6.06%124K
----
Restricted cash
-7.89%35K
-7.69%36K
11.11%40K
11.11%40K
60.87%37K
65.22%38K
-39.06%39K
-7.69%36K
-7.69%36K
--23K
Total current assets
-78.59%1.62M
-76.25%1.19M
-60.49%2.92M
-60.49%2.92M
-42.59%5.11M
-31.91%7.56M
-64.23%5.02M
-35.32%7.38M
-35.32%7.38M
--8.89M
Non current assets
Net PPE
-29.58%200K
-21.43%231K
-22.22%238K
-22.22%238K
-14.47%260K
-9.55%284K
-10.64%294K
1,510.53%306K
1,510.53%306K
--304K
-Gross PPE
-29.58%200K
-21.43%231K
-14.55%276K
-14.55%276K
-14.47%260K
-9.55%284K
-10.64%294K
1,245.83%323K
1,245.83%323K
--304K
-Accumulated depreciation
----
----
-123.53%-38K
-123.53%-38K
----
----
----
-240.00%-17K
-240.00%-17K
----
Other non current assets
-4.35%22K
0.00%23K
-4.35%22K
-4.35%22K
-38.24%21K
-34.29%23K
--23K
--23K
--23K
--34K
Total non current assets
-27.69%222K
-19.87%254K
-20.97%260K
-20.97%260K
-16.86%281K
-12.03%307K
-3.65%317K
1,631.58%329K
1,631.58%329K
--338K
Total assets
-76.60%1.84M
-72.90%1.45M
-58.81%3.18M
-58.81%3.18M
-41.65%5.39M
-31.30%7.87M
-62.84%5.34M
-32.55%7.71M
-32.55%7.71M
--9.23M
Liabilities
Current liabilities
Payables
16.74%3.51M
152.93%4.54M
192.97%1.46M
192.97%1.46M
246.36%2.81M
308.29%3.01M
46.01%1.79M
1,176.92%498K
1,176.92%498K
--811K
-accounts payable
36.06%1.48M
468.97%2.38M
192.97%1.46M
192.97%1.46M
343.20%913K
808.33%1.09M
132.78%419K
1,176.92%498K
1,176.92%498K
--206K
-Other payable
5.74%2.03M
56.55%2.15M
----
----
213.39%1.9M
210.88%1.92M
31.11%1.37M
----
----
--605K
Current accrued expenses
----
----
116.88%1.72M
116.88%1.72M
----
----
----
42.29%794K
42.29%794K
----
Current debt and capital lease obligation
----
----
7.81%69K
7.81%69K
----
----
----
--64K
--64K
----
-Current capital lease obligation
----
----
7.81%69K
7.81%69K
----
----
----
--64K
--64K
----
Current liabilities
16.74%3.51M
152.93%4.54M
100.41%3.46M
100.41%3.46M
246.36%2.81M
308.29%3.01M
46.01%1.79M
189.11%1.73M
189.11%1.73M
--811K
Non current liabilities
Long term debt and capital lease obligation
-65.38%36K
-56.35%55K
-50.34%73K
-50.34%73K
-51.45%84K
-45.26%104K
-39.13%126K
--147K
--147K
--173K
-Long term capital lease obligation
-65.38%36K
-56.35%55K
-50.34%73K
-50.34%73K
-51.45%84K
-45.26%104K
-39.13%126K
--147K
--147K
--173K
Derivative product liabilities
--0
630.36%3.85M
596.33%1.52M
596.33%1.52M
572.25%2.69M
812.30%6.3M
-35.42%527K
-88.07%218K
-88.07%218K
--400K
Total non current liabilities
-99.44%36K
497.86%3.9M
335.89%1.59M
335.89%1.59M
383.94%2.77M
627.36%6.41M
-36.17%653K
-80.03%365K
-80.03%365K
--573K
Total liabilities
-62.35%3.54M
245.01%8.44M
141.51%5.05M
141.51%5.05M
303.32%5.58M
482.13%9.41M
8.66%2.45M
-13.77%2.09M
-13.77%2.09M
--1.38M
Shareholders'equity
Share capital
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
-common stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
-8.30%-32.38M
-27.76%-31.53M
-54.27%-32.07M
-54.27%-32.07M
-65.09%-29.12M
-104.21%-29.9M
-121.08%-24.68M
-146.10%-20.79M
-146.10%-20.79M
---17.64M
Paid-in capital
8.20%30.68M
-11.00%24.53M
14.34%30.19M
14.34%30.19M
13.49%28.92M
15.84%28.36M
18.47%27.56M
51.30%26.41M
51.30%26.41M
--25.48M
Total stockholders'equity
-10.23%-1.7M
-342.06%-6.99M
-133.35%-1.87M
-133.35%-1.87M
-102.50%-196K
-115.71%-1.55M
-76.14%2.89M
-37.61%5.62M
-37.61%5.62M
--7.85M
Total equity
-10.23%-1.7M
-342.06%-6.99M
-133.35%-1.87M
-133.35%-1.87M
-102.50%-196K
-115.71%-1.55M
-76.14%2.89M
-37.61%5.62M
-37.61%5.62M
--7.85M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments -82.96%1.21M-83.34%735K-62.76%2.64M-62.76%2.64M-43.64%4.76M-31.67%7.09M-67.89%4.41M-35.91%7.09M-35.91%7.09M--8.44M
-Cash and cash equivalents -82.96%1.21M-45.92%735K-25.49%2.64M-25.49%2.64M7.89%4.76M63.00%7.09M-84.44%1.36M-67.97%3.54M-67.97%3.54M--4.41M
-Short-term investments ----------0--0--0--0-38.99%3.05M--3.55M--3.55M--4.03M
Receivables -13.36%376K-25.75%421K26.72%166K26.72%166K-27.29%309K-38.61%434K152.00%567K-26.40%131K-26.40%131K--425K
-Other receivables -13.36%376K-25.75%421K26.72%166K26.72%166K-27.29%309K-38.61%434K152.00%567K-26.40%131K-26.40%131K--425K
Prepaid assets ---------43.55%70K-43.55%70K-------------6.06%124K-6.06%124K----
Restricted cash -7.89%35K-7.69%36K11.11%40K11.11%40K60.87%37K65.22%38K-39.06%39K-7.69%36K-7.69%36K--23K
Total current assets -78.59%1.62M-76.25%1.19M-60.49%2.92M-60.49%2.92M-42.59%5.11M-31.91%7.56M-64.23%5.02M-35.32%7.38M-35.32%7.38M--8.89M
Non current assets
Net PPE -29.58%200K-21.43%231K-22.22%238K-22.22%238K-14.47%260K-9.55%284K-10.64%294K1,510.53%306K1,510.53%306K--304K
-Gross PPE -29.58%200K-21.43%231K-14.55%276K-14.55%276K-14.47%260K-9.55%284K-10.64%294K1,245.83%323K1,245.83%323K--304K
-Accumulated depreciation ---------123.53%-38K-123.53%-38K-------------240.00%-17K-240.00%-17K----
Other non current assets -4.35%22K0.00%23K-4.35%22K-4.35%22K-38.24%21K-34.29%23K--23K--23K--23K--34K
Total non current assets -27.69%222K-19.87%254K-20.97%260K-20.97%260K-16.86%281K-12.03%307K-3.65%317K1,631.58%329K1,631.58%329K--338K
Total assets -76.60%1.84M-72.90%1.45M-58.81%3.18M-58.81%3.18M-41.65%5.39M-31.30%7.87M-62.84%5.34M-32.55%7.71M-32.55%7.71M--9.23M
Liabilities
Current liabilities
Payables 16.74%3.51M152.93%4.54M192.97%1.46M192.97%1.46M246.36%2.81M308.29%3.01M46.01%1.79M1,176.92%498K1,176.92%498K--811K
-accounts payable 36.06%1.48M468.97%2.38M192.97%1.46M192.97%1.46M343.20%913K808.33%1.09M132.78%419K1,176.92%498K1,176.92%498K--206K
-Other payable 5.74%2.03M56.55%2.15M--------213.39%1.9M210.88%1.92M31.11%1.37M----------605K
Current accrued expenses --------116.88%1.72M116.88%1.72M------------42.29%794K42.29%794K----
Current debt and capital lease obligation --------7.81%69K7.81%69K--------------64K--64K----
-Current capital lease obligation --------7.81%69K7.81%69K--------------64K--64K----
Current liabilities 16.74%3.51M152.93%4.54M100.41%3.46M100.41%3.46M246.36%2.81M308.29%3.01M46.01%1.79M189.11%1.73M189.11%1.73M--811K
Non current liabilities
Long term debt and capital lease obligation -65.38%36K-56.35%55K-50.34%73K-50.34%73K-51.45%84K-45.26%104K-39.13%126K--147K--147K--173K
-Long term capital lease obligation -65.38%36K-56.35%55K-50.34%73K-50.34%73K-51.45%84K-45.26%104K-39.13%126K--147K--147K--173K
Derivative product liabilities --0630.36%3.85M596.33%1.52M596.33%1.52M572.25%2.69M812.30%6.3M-35.42%527K-88.07%218K-88.07%218K--400K
Total non current liabilities -99.44%36K497.86%3.9M335.89%1.59M335.89%1.59M383.94%2.77M627.36%6.41M-36.17%653K-80.03%365K-80.03%365K--573K
Total liabilities -62.35%3.54M245.01%8.44M141.51%5.05M141.51%5.05M303.32%5.58M482.13%9.41M8.66%2.45M-13.77%2.09M-13.77%2.09M--1.38M
Shareholders'equity
Share capital --0--0--0--0--0--0--0--0--0--0
-common stock --0--0--0--0--0--0--0--0--0--0
Retained earnings -8.30%-32.38M-27.76%-31.53M-54.27%-32.07M-54.27%-32.07M-65.09%-29.12M-104.21%-29.9M-121.08%-24.68M-146.10%-20.79M-146.10%-20.79M---17.64M
Paid-in capital 8.20%30.68M-11.00%24.53M14.34%30.19M14.34%30.19M13.49%28.92M15.84%28.36M18.47%27.56M51.30%26.41M51.30%26.41M--25.48M
Total stockholders'equity -10.23%-1.7M-342.06%-6.99M-133.35%-1.87M-133.35%-1.87M-102.50%-196K-115.71%-1.55M-76.14%2.89M-37.61%5.62M-37.61%5.62M--7.85M
Total equity -10.23%-1.7M-342.06%-6.99M-133.35%-1.87M-133.35%-1.87M-102.50%-196K-115.71%-1.55M-76.14%2.89M-37.61%5.62M-37.61%5.62M--7.85M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data